齊一生物科技(上海)有限公司作者
Anti-CD38抗體詳細(xì)說(shuō)明書
資料類型 | png文件 | 資料大小 | 23828 |
下載次數(shù) | 93 | 資料圖片 | 【點(diǎn)擊查看】 |
上 傳 人 | 齊一生物科技(上海)有限公司 | 需要積分 | 0 |
關(guān) 鍵 詞 | Anti-CD38抗體詳細(xì)說(shuō)明書 |
- 【資料簡(jiǎn)介】
產(chǎn)品類別 產(chǎn)品目錄 >> 一抗 >> 一抗
相關(guān)標(biāo)記 Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5
Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC
英文名稱 Anti-CD38
中文名稱 CD38抗體
別 名 Acute lymphoblastic leukemia cells antigen CD38; ADP ribosyl cyclase 1; ADP ribosyl cyclase; ADP ribosyl cyclase/cyclic ADP-ribose hydrolase; CADPr hydrolase 1; CD 38; CD38 antigen; Cd38-rs1; CD38H; Cyclic ADP ribose hydrolase 1; I-19; Lymphocyte differentiation antigen CD38; NIM-R5 antigen; NIMR5 antigen (mouse); p45; T10.
濃 度 1mg/1ml
克隆類型 polyclonal
交叉反應(yīng) Mouse, Rat,
產(chǎn)品類型 一抗
研究領(lǐng)域 腫瘤 免疫學(xué) 干細(xì)胞 糖尿病 細(xì)胞表面分子 自然殺傷細(xì)胞 淋巴細(xì)胞 t-淋巴細(xì)胞 b-淋巴細(xì)胞
蛋白分子量 predicted molecular weight: 34kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from mouse CD38 (101-150aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
相關(guān)產(chǎn)品 免疫組化常用試劑 免疫印跡常用試劑 各種標(biāo)記二抗產(chǎn)品介紹:
CD38 is a novel multifunctional ectoenzyme widely expressed in cells and tissues especially in leukocytes. CD38 also functions in cell adhesion, signal transduction and calcium signaling. CD38 antigen is an integral membrane glycoprotein, M.W. 45 kD. The CD38 antigen is present on approximay all pre-B lymphocytes, plasma cells and thymocytes. CD38 antigen is also expressed on activated T Lymphocytes, NK Cells, monocytes, myeloblasts and erythroblasts. CD38 is co-expressed on CD34+ cells,but is not expressed on pluripotent stem cells. CD38 antigen is present on T and B lymphoblastic leukemia (ALL), Burkitts' lymphoma, multiple myeloma and acute myeloid leukemia (AML).
Function : Synthesizes cyclic ADP-ribose, a second messenger for glucose-induced insulin secretion. Also has cADPr hydrolase activity. Also moonlights as a receptor in cells of the immune system.
Subcellular Location : Membrane; Single-pass type II membrane protein.
Tissue Specificity : Expressed at high levels in pancreas, liver, kidney, brain, testis, ovary, placenta, malignant lymphoma and neuroblastoma.
Similarity : Belongs to the ADP-ribosyl cyclase family.
CD38分子是單鏈Ⅱ型跨膜糖蛋白,存在于很多免疫細(xì)胞表面上,CD38與無(wú)脊椎動(dòng)物卵的授精、HIV感染、某些癌癥以及糖尿病等有關(guān),CD38具有許多復(fù)雜而又*的生物學(xué)特性及功能,有調(diào)控細(xì)胞鈣釋放的機(jī)制。主要表達(dá)于胸腺細(xì)胞、前T和前B細(xì)胞、活化的T和B細(xì)胞、單核細(xì)胞、NK細(xì)胞、漿細(xì)胞等,可用于急性白血病的分型和活化的T細(xì)胞在自身免疫和免疫缺陷中的作用等方面的研究,也可作為生發(fā)中心B細(xì)胞的一種選擇性標(biāo)記。
產(chǎn)品圖片Antigen: bs-0979P, 0.2ug/100ul
Primary: Antiserum, 1:500, 1:1000, 1:2000, 1:4000, 1:8000, 1:16000, 1:32000;
Secondary: HRP conjugated Goat Anti-Rabbit IgG(bs-0295G-HRP) at 1: 5000;
TMB(C-0024) staining;
Read the data in MicroplateReader by 450nm.
2024世環(huán)會(huì)【工業(yè)節(jié)能與環(huán)保展】

div6月3日,2024世環(huán)會(huì)【工業(yè)節(jié)能與環(huán)保展】于上海丨國(guó)家會(huì)展中[詳細(xì)]
- 凡本網(wǎng)注明"來(lái)源:環(huán)保在線"的所有作品,版權(quán)均屬于環(huán)保在線,轉(zhuǎn)載請(qǐng)必須注明環(huán)保在線,http://www.niunang.cn。違反者本網(wǎng)將追究相關(guān)法律責(zé)任。
- 企業(yè)發(fā)布的公司新聞、技術(shù)文章、資料下載等內(nèi)容,如涉及侵權(quán)、違規(guī)遭投訴的,一律由發(fā)布企業(yè)自行承擔(dān)責(zé)任,本網(wǎng)有權(quán)刪除內(nèi)容并追溯責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其它來(lái)源的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性,不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品來(lái)源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問(wèn)題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。